POINT BIOPHARMA GLOBAL INC. Earnings Per Share (Basic)
POINT BIOPHARMA GLOBAL INC. reported Earnings Per Share (Basic) of -$0.23 per share for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. earnings per share, basic for the quarter ending 2023-09-30 was -$0.23.
- POINT BIOPHARMA GLOBAL INC. earnings per share, basic for the quarter ending 2023-06-30 was -$0.24.
- POINT BIOPHARMA GLOBAL INC. earnings per share, basic for the quarter ending 2023-03-31 was -$0.16.
- POINT BIOPHARMA GLOBAL INC. earnings per share, basic for the quarter ending 2022-12-31 was $1.54.
- POINT BIOPHARMA GLOBAL INC. earnings per share, basic for fiscal 2022 was $1.04.
- POINT BIOPHARMA GLOBAL INC. earnings per share, basic for fiscal 2021 was -$0.62.
- POINT BIOPHARMA GLOBAL INC. earnings per share, basic for fiscal 2020 was -$0.34.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$0.23 10-Q · filed 2023-11-13 | -$0.47 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.63 10-Q · filed 2023-11-13 | $0.91 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2023-06-30 | -$0.24 10-Q · filed 2023-08-14 | -$0.40 10-Q · filed 2023-08-14 | $1.15 derived: net income ÷ weighted average shares · filed 2023-11-13 | $0.95 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2023-03-31 | -$0.16 10-Q · filed 2023-05-15 | $1.39 derived: net income ÷ weighted average shares · filed 2023-11-13 | $1.21 derived: net income ÷ weighted average shares · filed 2023-11-13 | $1.00 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2022-12-31 | $1.54 derived: net income ÷ weighted average shares · filed 2023-03-27 | $1.41 derived: net income ÷ weighted average shares · filed 2023-11-13 | $1.19 derived: net income ÷ weighted average shares · filed 2023-11-13 | $1.04 10-K · filed 2023-03-27 |
| 2022-09-30 | -$0.26 10-Q · filed 2023-11-13 | -$0.53 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.71 10-Q · filed 2023-11-13 | -$0.87 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2022-06-30 | -$0.27 10-Q · filed 2023-08-14 | -$0.45 10-Q · filed 2023-08-14 | -$0.61 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.80 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2022-03-31 | -$0.18 10-Q · filed 2023-05-15 | -$0.34 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.53 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.69 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2021-12-31 | -$0.16 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$0.35 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$0.51 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$0.62 10-K · filed 2023-03-27 |
| 2021-09-30 | -$0.19 10-Q · filed 2022-11-14 | -$0.35 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.46 10-Q · filed 2022-11-14 | -$0.49 derived: net income ÷ weighted average shares · filed 2022-11-14 |
| 2021-06-30 | -$0.15 10-Q · filed 2022-08-12 | -$0.26 10-Q · filed 2022-08-12 | -$0.26 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.32 derived: net income ÷ weighted average shares · filed 2022-11-14 |
| 2021-03-31 | -$0.10 10-Q · filed 2022-05-13 | -$0.11 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.16 derived: net income ÷ weighted average shares · filed 2022-11-14 | |
| 2020-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$0.06 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$0.34 10-K · filed 2022-03-25 | |
| 2020-09-30 | -$0.06 10-Q · filed 2021-11-12 | -$0.23 10-Q · filed 2021-11-12 |